stonks4u
Sign up free
VREOF logo

VREOF Vireo Growth Inc.

Other OTC · Drug Manufacturers - Specialty & Generic · Healthcare

$10.80
+0.04 (+0.39%)

Vireo Growth Inc. operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, Missouri, Nevada, New York, and Utah. It sells cannabis products through a network of retail dispensaries and distributors. The company was formerly known as Goodness Growth Holdings, Inc. and changed its name to Vireo Growth Inc…

Market Cap: $413.13Mwww.vireogrowth.com

Price (90d)

No price history yet — the daily price refresh runs once a day.

Signal Score (90d)

120
120
Aug 11Aug 11

Quote

Day Range
$10.74 – $10.89
52-Week Range
$8.91 – $22.50
Volume
$1.6K
Market Cap
$413.13M
50-Day Avg
$10.50
200-Day Avg
$13.52
Prev Close
$10.76
Open
$10.89

Valuation & Ratios

P/E Ratio
-6.50
EPS
$-2.78
P/B Ratio
1.47
P/S Ratio
1.68
Debt/Equity
0.99
Current Ratio
1.59
Dividend Yield
+0.0%
Gross Margin
+47.3%

Returns & Efficiency

Return on Equity
-22.2%
Return on Assets
-8.3%
FCF Yield
-5.8%
EV/EBITDA
53.00

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$268.77M$-68.11M$-2.83
2024$99.38M$-28.01M$-4.80
2023$88.13M$-25.55M$-5.70
2022$74.63M$-42.46M$-9.90
2021$54.45M$-33.69M$-8.10

Social Signal Score

70
5d
70
1 mentions
—
30d
70
1 mentions
—
60d
70
1 mentions
—
90d
70
1 mentions
—
news: 1

Earnings

Wed, Nov 11(in 3 months)

Consensus estimate $0.30 per share

2of 7 quarters beat consensus

Typical surprise -200.0% (median, so one quarter with a near-zero estimate can't distort it)

  • Tue, Aug 11$0.24 vs $0.17beat
  • Tue, May 12$-0.60 vs $0.15miss
  • Tue, Mar 17$-0.01 vs $0.01miss
  • Wed, Nov 12$-0.02 vs $0.01miss
  • Wed, Aug 13$-0.02 vs $-0.01miss
  • Fri, May 9$-0.02 vs $-0.02beat

Estimates and results for VREOF via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

VREOFhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.

Mentions (1)

  • Newsseekingalpha.com·4d ago·Positive

    Vireo Growth Inc. (VREOF) Q2 2026 Earnings Call Transcript Vireo Growth Inc. (VREOF) Q2 2026 Earnings Call Transcript

    View source ↗